Epigenomic signatures of accelerated epigenetic aging are associated with congenital heart disease in newborns

Abstract Background Congenital heart disease (CHD) lesions are the most common birth defects and despite advances in care, are associated with short- and long-term co-morbidities. The exact mechanisms that may influence outcomes in survivors with CHD remain unclear and are likely multi-factorial; ex...

Full description

Saved in:
Bibliographic Details
Main Authors: Kristen Kocher, Julius Ngwa, Surajit Bhattacharya, Mary Donofrio, Catherine Limperopoulos, Nickie Andescavage
Format: Article
Language:English
Published: BMC 2025-07-01
Series:BMC Medical Genomics
Subjects:
Online Access:https://doi.org/10.1186/s12920-025-02189-2
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849331783974256640
author Kristen Kocher
Julius Ngwa
Surajit Bhattacharya
Mary Donofrio
Catherine Limperopoulos
Nickie Andescavage
author_facet Kristen Kocher
Julius Ngwa
Surajit Bhattacharya
Mary Donofrio
Catherine Limperopoulos
Nickie Andescavage
author_sort Kristen Kocher
collection DOAJ
description Abstract Background Congenital heart disease (CHD) lesions are the most common birth defects and despite advances in care, are associated with short- and long-term co-morbidities. The exact mechanisms that may influence outcomes in survivors with CHD remain unclear and are likely multi-factorial; exploring the epigenome in these cases may provide novel insights into predictive biomarkers contributing to outcomes. The present study characterizes the impact of CHD on the newborn epigenome through assessments of epigenetic age. Methods This is a prospective, single-site case–control pilot study conducted at Children’s National Hospital with subjects enrolled from the Washington DC Metropolitan area. Genomic samples were collected between 2018 and 2024 and analyzed using the Illumina MethylationEPIC BeadChip array platform. PedBE was used to assess infant biological age acceleration. Results Using a methylation array approach, we analyzed the epigenetic age of 33 newborns with complex CHD requiring neonatal cardiac surgery and 26 healthy controls. There was a significant accelerated epigenetic age in newborns with CHD (+ 72.9 days) compared to newborns from uncomplicated pregnancies (+ 13.9 days, p < 0.001, unadjusted). Further subgroup analysis within the CHD cohort revealed that both single- (+ 56.6 days) and two-ventricle CHD (+ 64.8 days) displayed significant accelerated epigenetic age, with transposition of the great arteries (TGA) cases having the greatest accelerated age (107.2 days, p = 0.0001). Stepwise analysis of clinical measures in the CHD group revealed significant age acceleration was associated with low blood oxygen saturation. Conclusions This pilot study reveals accelerated epigenetic aging in newborns with critical CHD compared to healthy controls. Though the mechanisms behind these findings are not well-defined, the association between postnatal measures of oxygen saturation and epigenetic age suggests hypoxia may play a significant role and should be explored in future studies.
format Article
id doaj-art-f905f010e4aa4e0f80d24dac3aa4de47
institution Kabale University
issn 1755-8794
language English
publishDate 2025-07-01
publisher BMC
record_format Article
series BMC Medical Genomics
spelling doaj-art-f905f010e4aa4e0f80d24dac3aa4de472025-08-20T03:46:24ZengBMCBMC Medical Genomics1755-87942025-07-0118111110.1186/s12920-025-02189-2Epigenomic signatures of accelerated epigenetic aging are associated with congenital heart disease in newbornsKristen Kocher0Julius Ngwa1Surajit Bhattacharya2Mary Donofrio3Catherine Limperopoulos4Nickie Andescavage5The Developing Brain Institute, Children’s National HospitalThe Developing Brain Institute, Children’s National HospitalCenter for Genetic Medicine Research, Children’s National HospitalDivision of Cardiology, Children’s National HospitalThe Developing Brain Institute, Children’s National HospitalThe Developing Brain Institute, Children’s National HospitalAbstract Background Congenital heart disease (CHD) lesions are the most common birth defects and despite advances in care, are associated with short- and long-term co-morbidities. The exact mechanisms that may influence outcomes in survivors with CHD remain unclear and are likely multi-factorial; exploring the epigenome in these cases may provide novel insights into predictive biomarkers contributing to outcomes. The present study characterizes the impact of CHD on the newborn epigenome through assessments of epigenetic age. Methods This is a prospective, single-site case–control pilot study conducted at Children’s National Hospital with subjects enrolled from the Washington DC Metropolitan area. Genomic samples were collected between 2018 and 2024 and analyzed using the Illumina MethylationEPIC BeadChip array platform. PedBE was used to assess infant biological age acceleration. Results Using a methylation array approach, we analyzed the epigenetic age of 33 newborns with complex CHD requiring neonatal cardiac surgery and 26 healthy controls. There was a significant accelerated epigenetic age in newborns with CHD (+ 72.9 days) compared to newborns from uncomplicated pregnancies (+ 13.9 days, p < 0.001, unadjusted). Further subgroup analysis within the CHD cohort revealed that both single- (+ 56.6 days) and two-ventricle CHD (+ 64.8 days) displayed significant accelerated epigenetic age, with transposition of the great arteries (TGA) cases having the greatest accelerated age (107.2 days, p = 0.0001). Stepwise analysis of clinical measures in the CHD group revealed significant age acceleration was associated with low blood oxygen saturation. Conclusions This pilot study reveals accelerated epigenetic aging in newborns with critical CHD compared to healthy controls. Though the mechanisms behind these findings are not well-defined, the association between postnatal measures of oxygen saturation and epigenetic age suggests hypoxia may play a significant role and should be explored in future studies.https://doi.org/10.1186/s12920-025-02189-2Congenital heart diseaseDNA methylationEpigenetic agingEpigenomics
spellingShingle Kristen Kocher
Julius Ngwa
Surajit Bhattacharya
Mary Donofrio
Catherine Limperopoulos
Nickie Andescavage
Epigenomic signatures of accelerated epigenetic aging are associated with congenital heart disease in newborns
BMC Medical Genomics
Congenital heart disease
DNA methylation
Epigenetic aging
Epigenomics
title Epigenomic signatures of accelerated epigenetic aging are associated with congenital heart disease in newborns
title_full Epigenomic signatures of accelerated epigenetic aging are associated with congenital heart disease in newborns
title_fullStr Epigenomic signatures of accelerated epigenetic aging are associated with congenital heart disease in newborns
title_full_unstemmed Epigenomic signatures of accelerated epigenetic aging are associated with congenital heart disease in newborns
title_short Epigenomic signatures of accelerated epigenetic aging are associated with congenital heart disease in newborns
title_sort epigenomic signatures of accelerated epigenetic aging are associated with congenital heart disease in newborns
topic Congenital heart disease
DNA methylation
Epigenetic aging
Epigenomics
url https://doi.org/10.1186/s12920-025-02189-2
work_keys_str_mv AT kristenkocher epigenomicsignaturesofacceleratedepigeneticagingareassociatedwithcongenitalheartdiseaseinnewborns
AT juliusngwa epigenomicsignaturesofacceleratedepigeneticagingareassociatedwithcongenitalheartdiseaseinnewborns
AT surajitbhattacharya epigenomicsignaturesofacceleratedepigeneticagingareassociatedwithcongenitalheartdiseaseinnewborns
AT marydonofrio epigenomicsignaturesofacceleratedepigeneticagingareassociatedwithcongenitalheartdiseaseinnewborns
AT catherinelimperopoulos epigenomicsignaturesofacceleratedepigeneticagingareassociatedwithcongenitalheartdiseaseinnewborns
AT nickieandescavage epigenomicsignaturesofacceleratedepigeneticagingareassociatedwithcongenitalheartdiseaseinnewborns